Racial and sex disparities in hepatocellular carcinoma in the USA
Abstract Purpose of Review In this review, we aim to provide a summary of the current
literature on race and gender disparities in hepatocellular carcinoma (HCC) incidence …
literature on race and gender disparities in hepatocellular carcinoma (HCC) incidence …
Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma
Background Fragmented cancer care (FC), or care received from multiple institutions,
increases systemic health care costs and potentiates cancer care disparities. There is a …
increases systemic health care costs and potentiates cancer care disparities. There is a …
[HTML][HTML] Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity
PS Pinheiro, KE Callahan, PD Jones, C Morris… - JHEP Reports, 2019 - Elsevier
Background & Aims Liver cancer is highly fatal and the most rapidly increasing cancer in the
US, where chronic hepatitis C (HCV) infection is the leading etiology. HCV is particularly …
US, where chronic hepatitis C (HCV) infection is the leading etiology. HCV is particularly …
Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities
H Nassereldine, K Compton, P Kendrick, Z Li… - The Lancet Public …, 2024 - thelancet.com
Background Understanding how specific populations are affected by liver cancer is
important for identifying priorities, policies, and interventions to mitigate health risks and …
important for identifying priorities, policies, and interventions to mitigate health risks and …
Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma
RP Thylur, SK Roy, A Shrivastava, TA LaVeist… - JGH …, 2020 - Wiley Online Library
Despite improved screening and surveillance guidelines, significant race/ethnicity‐specific
disparities in hepatocellular carcinoma (HCC) continue to exist and disproportionately affect …
disparities in hepatocellular carcinoma (HCC) continue to exist and disproportionately affect …
Glycopeptides with Sialyl Lewis antigen in serum haptoglobin as candidate biomarkers for nonalcoholic steatohepatitis hepatocellular carcinoma using a higher …
Y Lin, J Zhu, J Zhang, J Dai, S Liu, A Arroyo, M Rose… - ACS …, 2022 - ACS Publications
Nonalcoholic steatohepatitis (NASH) is the fastest growing cause of hepatocellular
carcinoma (HCC) in the United States. Changes in N-glycosylation on specific glycosites of …
carcinoma (HCC) in the United States. Changes in N-glycosylation on specific glycosites of …
Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma
Á Rojas, A Gil‐Gómez, P de la Cruz‐Ojeda… - Liver …, 2022 - Wiley Online Library
Abstract Background and Aims Liver cancer stem cells (CSCs) could be involved in the
carcinogenesis, recurrence, metastasis and chemoresistance of hepatocellular carcinoma …
carcinogenesis, recurrence, metastasis and chemoresistance of hepatocellular carcinoma …
A panel of glycopeptides as candidate biomarkers for early diagnosis of NASH hepatocellular carcinoma using a stepped HCD method and PRM evaluation
Y Lin, J Zhu, L Pan, J Zhang, Z Tan… - Journal of proteome …, 2021 - ACS Publications
Changes in N-glycosylation on specific peptide sites of serum proteins have been
investigated as potential markers for diagnosis of nonalcoholic steatohepatitis (NASH) …
investigated as potential markers for diagnosis of nonalcoholic steatohepatitis (NASH) …
Comparative analysis of nonalcoholic steatohepatitis–versus viral hepatitis–and alcohol-related liver disease–related hepatocellular carcinoma
Background: Despite an increasing burden of nonalcoholic steatohepatitis (NASH), limited
data are available comparing outcomes of NASH-related hepatocellular carcinoma (HCC) …
data are available comparing outcomes of NASH-related hepatocellular carcinoma (HCC) …
County differences in liver mortality in the United States: impact of sociodemographics, disease risk factors, and access to care
Background and Aims Data have demonstrated state-wide variability in mortality rates from
liver disease (cirrhosis+ hepatocellular carcinoma), but data are lacking at the local level …
liver disease (cirrhosis+ hepatocellular carcinoma), but data are lacking at the local level …